Page last updated: 2024-08-21

malondialdehyde and Familial Combined Hyperlipidemia

malondialdehyde has been researched along with Familial Combined Hyperlipidemia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ascaso, JF; Carmena, R; Chaves, FJ; Ivorra, C; Martinez-Hervas, S; Pallardo, FV; Priego, A; Real, JT; Redon, J; ViƱa, JR1
Blesa, S; Carmena, R; Chaves, FJ; Gonzalez-Albert, V; Mansego, ML; Martinez, F; Martinez-Hervas, S; Real, JT; Redon, J; Saez, GT1
Bujo, H; Itou, N; Saito, Y; Shibasaki, M; Taira, K; Takahashi, K; Yamazaki, K1

Other Studies

3 other study(ies) available for malondialdehyde and Familial Combined Hyperlipidemia

ArticleYear
Increased plasma xanthine oxidase activity is related to nuclear factor kappa beta activation and inflammatory markers in familial combined hyperlipidemia.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2010, Volume: 20, Issue:10

    Topics: Adult; Atherosclerosis; Biomarkers; C-Reactive Protein; Endothelium, Vascular; Female; Free Radicals; Humans; Hyperlipidemia, Familial Combined; Inflammation; Insulin Resistance; Interleukin-6; Lipid Peroxidation; Lipids; Logistic Models; Male; Malondialdehyde; Middle Aged; Multivariate Analysis; NF-kappa B; Oxidative Stress; Xanthine Oxidase

2010
Different impacts of cardiovascular risk factors on oxidative stress.
    International journal of molecular sciences, 2011, Volume: 12, Issue:9

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Biomarkers; Cardiovascular Diseases; Catalase; Deoxyguanosine; Female; Gene Expression Profiling; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Synthase; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hypertension; Male; Malondialdehyde; Middle Aged; NADPH Oxidases; Oxidative Stress; Phosphoproteins; Risk Factors; Superoxide Dismutase

2011
Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.
    Atherosclerosis, 2004, Volume: 172, Issue:1

    Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hyperlipidemia, Familial Combined; Lipase; Lipoproteins, LDL; Liver; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Polymorphism, Genetic

2004